Accelerating the delivery of innovative, new medicines.
Our new CEO Perry Nisen, M.D., Ph.D. on the evolution of modern medical research.
How the Might Family is Changing the Way We Study Rare Childhood Diseases
Landmark Gift Launches 10-Year Vision
Hybrid Scientist Bridges Basic Research and Drug Discovery
Key Advances in Therapeutics Target Rare Bone Disease and Obesity
Speeding Discoveries to Patients
Building High-Yield Partnerships
The Power of Philanthropy
The Role of Big Data in Medical Research
Developing Nanotechnology Therapies for Traumatic Brain Injuries
Subscribe to our monthly email newsletter Discoveries.
Follow us on social media for the latest from Sanford Burnham Prebys.